NYSE American - Delayed Quote USD
Theriva Biologics, Inc. (TOVX)
0.4700
-0.0010
(-0.21%)
At close: June 6 at 4:00:00 PM EDT
0.4698
-0.00
(-0.04%)
After hours: June 6 at 7:50:47 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-16,812
-16,937
-18,996
-19,082
-12,890
Investing Cash Flow
-1
-1
-202
-4,396
-14
Financing Cash Flow
8,568
5,496
625
-1,930
74,002
End Cash Position
10,115
11,705
23,279
41,885
67,325
Capital Expenditure
--
-1
-202
-116
-14
Issuance of Capital Stock
--
5,563
2,219
2,734
65,960
Repayment of Debt
-123
-67
-75
-1,376
0
Repurchase of Capital Stock
--
--
0
-288
0
Free Cash Flow
-16,813
-16,938
-19,198
-19,198
-12,904
12/31/2021 - 12/18/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GLYC GlycoMimetics, Inc.
0.1938
-2.42%
SILO Silo Pharma, Inc.
0.5811
-9.20%
REVB Revelation Biosciences, Inc.
0.8594
+5.45%
VTYX Ventyx Biosciences, Inc.
2.4600
+9.33%
PSTV Plus Therapeutics, Inc.
0.3255
+2.04%
TRAW Traws Pharma, Inc.
1.6500
+11.49%
CDT Conduit Pharmaceuticals Inc.
2.6900
-0.37%
KPRX Kiora Pharmaceuticals, Inc.
3.0800
-0.32%
IMNN Imunon, Inc.
1.4600
+4.29%
OGEN Oragenics, Inc.
4.2800
+21.25%